Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hippius

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
Psychopharmacology|January 1, 1989
Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia--a retrospective study of 387 patientsD Naber, M Leppig, R Grohmann, et al.
Der Nervenarzt|September 1, 1984
[Modern sleep research]R Steinberg, H Hippius, N Nedopil, et al.
Arzneimittel-Forschung|July 1, 1970
[Clinical studies with a new piperidyl-phenothiazine derivative (A 124)]H Berzewski, H Hippius, H Petri, et al.
Lancet (London, England)|August 30, 2000
Antipsychotic drugs and venous thromboembolismJ Wolstein, R Grohmann, E Rüther, et al.
Pharmacopsychiatry|March 31, 2004
The AMSP drug safety program: methods and global resultsR Grohmann, R R Engel, E Rüther, et al.
Der Nervenarzt|February 1, 1988
[Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors]K von Oefele, R Grohmann, H Hippius, et al.
Pharmacopsychiatry|March 31, 2004
Research methods in drug surveillanceR R Engel, R Grohmann, E Rüther, et al.
Der Nervenarzt|October 1, 1988
[Biological markers of endogenous psychoses]B Bondy, M Ackenheil, F Müller-Spahn, et al.
Pharmacopsychiatry|March 10, 1999
Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRIR Grohmann, E Rüther, R R Engel, et al.
Acta Psychiatrica Scandinavica|July 1, 1989
Psychotropic drug use in a representative community sample: the Upper Bavarian studyM M Fichter, W Witzke, K Leibl, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Psychopharmacology|January 1, 1989
Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia--a retrospective study of 387 patientsD Naber, M Leppig, R Grohmann, et al.
Der Nervenarzt|September 1, 1984
[Modern sleep research]R Steinberg, H Hippius, N Nedopil, et al.
Arzneimittel-Forschung|July 1, 1970
[Clinical studies with a new piperidyl-phenothiazine derivative (A 124)]H Berzewski, H Hippius, H Petri, et al.
Lancet (London, England)|August 30, 2000
Antipsychotic drugs and venous thromboembolismJ Wolstein, R Grohmann, E Rüther, et al.
Pharmacopsychiatry|March 31, 2004
The AMSP drug safety program: methods and global resultsR Grohmann, R R Engel, E Rüther, et al.
Der Nervenarzt|February 1, 1988
[Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors]K von Oefele, R Grohmann, H Hippius, et al.
Pharmacopsychiatry|March 31, 2004
Research methods in drug surveillanceR R Engel, R Grohmann, E Rüther, et al.
Der Nervenarzt|October 1, 1988
[Biological markers of endogenous psychoses]B Bondy, M Ackenheil, F Müller-Spahn, et al.
Pharmacopsychiatry|March 10, 1999
Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRIR Grohmann, E Rüther, R R Engel, et al.
Acta Psychiatrica Scandinavica|July 1, 1989
Psychotropic drug use in a representative community sample: the Upper Bavarian studyM M Fichter, W Witzke, K Leibl, et al.
Pageof 15